The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global life science analytics market grew at a CAGR of around 12% during 2015-2020. Looking forward, IMARC Group expects the market to exhibit strong growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Life science analytics refers to the systematic computational analysis of biological data to gain insights regarding living organisms. It involves descriptive, predictive and prescriptive analytics that utilizes artificial intelligence (AI), big data and machine learning (ML) solutions and advanced devices. These technologies aid in clinical research, medical trials, disease diagnosis, drug discovery and development, sales and marketing, supply chain management and pharmacovigilance. Life science analytics also aid in the early detection of pathology and the development of effective treatment alternatives.
Significant growth in the life science industry, along with the increasing requirement for analytical insights for clinical trials, is one of the key factors creating a positive outlook for the market. Moreover, the widespread adoption of life science analytics solutions for data standardization for managing chronic diseases is also driving the market growth. In line with this, as the coronavirus disease (COVID-19) continues to spread across the globe, there has been a significant increase in the need for effective teleconsultation solutions for improved patient data management. Additionally, various technological advancements, such as the development of innovative telemedicine, mhealth and e-prescribing tools, are acting as other growth-inducing factors. These analytics solutions are also widely used to develop precision and personalized medicines that use specific genomic data of the patients with specific medical requirements. Other factors, including improvements in the existing healthcare infrastructure, along with extensive research and development (R&D) activities, are anticipated to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global life science analytics market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on type, component, deployment mode, application and end use.
Breakup by Type:
Breakup by Component:
Breakup by Deployment Mode:
Breakup by Application:
Breakup by End Use:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture Plc, Cognizant, Infosys Limited, International Business Machines Corporation, IQVIA Inc., Oracle Corporation, Rockwell Automation Inc., SAS Institute Inc., TAKE Solutions Limited and Wipro Limited.
|Base Year of the Analysis||2020|
|Segment Coverage||Type, Component, Deployment Mode, Application, End Use, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Accenture Plc, Cognizant, Infosys Limited, International Business Machines Corporation, IQVIA Inc., Oracle Corporation, Rockwell Automation Inc., SAS Institute Inc., TAKE Solutions Limited and Wipro Limited|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at